MethylGene

Biotechnology Research • Canada • 11-20 Employees

Company overview

Headquarters	Canada
Phone number	+15143373333
Website	methylgene.com
NAICS	541714
Founded	1997
Employees	11-20

Key Contacts at MethylGene

Stern Ligia

Director Clinical Operations

Stern Ligia

Director Clinical Operations

MethylGene Email Formats

MethylGene uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	42.1%
{first name}@company.com	john@company.com	25.3%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	14.8%
{first name}{last name}@company.com	johndoe@company.com	10.2%
{last name}@company.com	doe@company.com	7.6%

About MethylGene

MethylGene Inc. (TSX: MYG) is a clinical-stage biopharmaceutical company that develops novel therapeutics for cancer and infectious disease. The Company’s lead product candidates include: MGCD265, an oral Met/VEGFR kinase inhibitor that is in Phase 1/2 clinical trials for solid tumor cancers and MGCD290, a fungal Hos2 inhibitor, for use in combination with fluconazole for fungal infections, which has completed Phase 1 clinical studies. The Company’s partners include Otsuka Pharmaceutical Co. Ltd., Taiho Pharmaceutical Co. Ltd., and EnVivo Pharmaceuticals, Inc. About MGCD265 MGCD265 is a novel, orally active small molecule inhibitor that targets a unique spectrum of receptor tyrosine kinases: Met, VEGFR 1, 2, and 3, Tie-2 and Ron. These kinases play key roles in tumor development, survival and metastasis as well as the inappropriate formation of blood vessels (angiogenesis) that nourish the tumor. MGCD265 is nearing completion of two Phase 1 single agent clinical trials and one Phase 1/2 combination clinical trial (with erlotinib and docetaxel) in solid tumors.

MethylGene revenue & valuation

Annual revenue	$21,500,000
Revenue per employee	$1,530,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$68,600,000
Total funding	No funding

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Manager

Director

Employees by Department

MethylGene has 10 employees across 4 departments.

Departments

Number of employees

Funding Data

MethylGene has never raised funding before.

Frequently asked questions

MethylGene is located in CA.

You can reach MethylGene at +15143373333.

MethylGene was founded in 1997, making it 29 years old. The company has established itself as a significant player in its industry over this time.

MethylGene has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at MethylGene

Stern Ligia

Director Clinical Operations

Stern Ligia

Director Clinical Operations

4.8

40,000 users